If you liked this article you might like

Who Wins, Who Loses in the MedImmune-Aviron Deal

Who Wins, Who Loses in the MedImmune-Aviron Deal

Biotech Bonus

Biotech Bonus

MedImmune Fattens Its Drug Pipeline by Buying Aviron

MedImmune Fattens Its Drug Pipeline by Buying Aviron

Aviron Says Flu Drug Won't Be as Late as Feared

Aviron Says Flu Drug Won't Be as Late as Feared